{"id":1641,"date":"2007-11-03T09:40:11","date_gmt":"2007-11-03T09:40:11","guid":{"rendered":"http:\/\/localhost:8888\/wordpress\/questionable_relationships_bet_1\/"},"modified":"2024-12-17T16:11:01","modified_gmt":"2024-12-17T21:11:01","slug":"questionable-relationships-bet-1","status":"publish","type":"post","link":"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/","title":{"rendered":"Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies"},"content":{"rendered":"<p>In many of the medical negligence and pharmaceutical liability cases our lawyers handle, we find numerous perks being provided to prescribing physicians by drug companies.<\/p>\n<p>The New England Journal of Medicine,  the most prestigious medical journal in the country, has published an article concerning the relationship between doctors and drug companies.  The article reports that several United States Senators have introduced a bill in the United States Congress that would require manufacturers of drugs and medical devices with annual revenues of more than $100 million to disclose the amount of money they give to physicians, in any form such as free dinners, vacations or consulting fees.  Five states require such disclosures at the present time.<\/p>\n<p>The article reports that the nature, extent and consequences of physicians\u2019 relationships with the pharmaceutical and medical device industry is one of the most fiercely debated issues among health care providers.  The relationships are seemingly everywhere according to the article.  A recent study reported that almost all physicians, (94%) have some type of relationship with the industry.  Most commonly, doctors reported receiving food and beverages in the work place, or being given drug samples by manufacturers\u2019 representative.   More than a third of the physicians reported receiving reimbursement for costs associated with professional meetings or continuing medical education; and,  more than one quarter, (28%), receive payments for consulting, speaking or referring patients for medical study trials.<\/p>\n<div class=\"read_more_link\"><a href=\"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/\"  title=\"Continue Reading Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies\" class=\"more-link\">Continue reading<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In many of the medical negligence and pharmaceutical liability cases our lawyers handle, we find numerous perks being provided to prescribing physicians by drug companies. The New England Journal of Medicine, the most prestigious medical journal in the country, has published an article concerning the relationship between doctors and drug companies. The article reports that [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[44],"class_list":["post-1641","post","type-post","status-publish","format-standard","hentry","category-personal-injury-wrongful-death","tag-personal-injury"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies &#8212; Trial Attorney Blog &#8212; November 3, 2007<\/title>\n<meta name=\"description\" content=\"In many of the medical negligence and pharmaceutical liability cases our lawyers handle, we find numerous perks being provided to prescribing physicians &#8212; November 3, 2007\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies &#8212; Trial Attorney Blog &#8212; November 3, 2007\" \/>\n<meta name=\"twitter:description\" content=\"In many of the medical negligence and pharmaceutical liability cases our lawyers handle, we find numerous perks being provided to prescribing physicians &#8212; November 3, 2007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Finch McCranie, LLP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies &#8212; Trial Attorney Blog &#8212; November 3, 2007","description":"In many of the medical negligence and pharmaceutical liability cases our lawyers handle, we find numerous perks being provided to prescribing physicians &#8212; November 3, 2007","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/","twitter_card":"summary_large_image","twitter_title":"Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies &#8212; Trial Attorney Blog &#8212; November 3, 2007","twitter_description":"In many of the medical negligence and pharmaceutical liability cases our lawyers handle, we find numerous perks being provided to prescribing physicians &#8212; November 3, 2007","twitter_misc":{"Written by":"Finch McCranie, LLP","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/","url":"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/","name":"Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies &#8212; Trial Attorney Blog &#8212; November 3, 2007","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#website"},"datePublished":"2007-11-03T09:40:11+00:00","dateModified":"2024-12-17T21:11:01+00:00","author":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4"},"description":"In many of the medical negligence and pharmaceutical liability cases our lawyers handle, we find numerous perks being provided to prescribing physicians &#8212; November 3, 2007","breadcrumb":{"@id":"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.finchmccranie.com\/blog\/questionable-relationships-bet-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.finchmccranie.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Drug Liability Issues Raised By Questionable Relationships Between Doctors and Drug Companies"}]},{"@type":"WebSite","@id":"https:\/\/www.finchmccranie.com\/blog\/#website","url":"https:\/\/www.finchmccranie.com\/blog\/","name":"Trial Attorney Blog","description":"Published by Georgia Trial Lawyers \u2014 Finch McCranie, LLP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.finchmccranie.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4","name":"Finch McCranie, LLP","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","caption":"Finch McCranie, LLP"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/comments?post=1641"}],"version-history":[{"count":1,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1641\/revisions"}],"predecessor-version":[{"id":33529,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1641\/revisions\/33529"}],"wp:attachment":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/media?parent=1641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/categories?post=1641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/tags?post=1641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}